Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Addus Homecare Corp (NQ: ADUS )

120.84 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Addus Homecare Corp

< Previous 1 2 3 Next >
Assessing Addus HomeCare: Insights From 9 Financial Analysts
Via Benzinga
The Analyst Verdict: Addus HomeCare In The Eyes Of 9 Experts
Via Benzinga
Demystifying Addus HomeCare: Insights From 8 Analyst Reviews
Via Benzinga
AdaptHealth Stock Earns RS Rating Upgrade
AdaptHealth stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 70 to 81. 
Via Investor's Business Daily
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Via Benzinga
Reasonable growth and debt and a high ROIC for ADDUS HOMECARE CORP (NASDAQ:ADUS).
ADDUS HOMECARE CORP (NASDAQ:ADUS) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
Analyst Scoreboard: 6 Ratings For Addus HomeCare
Via Benzinga
Exploring ADDUS HOMECARE CORP (NASDAQ:ADUS)s quality characteristics.
Why Quality Investors Should Delve into ADDUS HOMECARE CORP (NASDAQ:ADUS) for Investment Opportunities. 
Via Chartmill
Why NASDAQ:ADUS Stands Out as a Quality Stock.
Exploring ADDUS HOMECARE CORP (NASDAQ:ADUS)'s quality characteristics. 
Via Chartmill
The Analyst Verdict: Addus HomeCare In The Eyes Of 8 Experts
Via Benzinga
ADUS Stock Earnings: Addus HomeCare Beats EPS, Beats Revenue for Q2 2024
ADUS stock results show that Addus HomeCare beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Small-Cap Stocks Ready to Deliver Jumbo-Sized Gains
Here are three small-cap stocks offering investors a unique opportunity to diversify their portfolio and maximize returns. 
Via InvestorPlace
Microsoft To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Examining the Quality Attributes of NASDAQ:ADUS.
Should you consider ADDUS HOMECARE CORP (NASDAQ:ADUS) for quality investing? 
Via Chartmill
7 Analysts Assess Addus HomeCare: What You Need To Know
Via Benzinga
ADUS Stock Earnings: Addus HomeCare Beats EPS, Beats Revenue for Q1 2024
ADUS stock results show that Addus HomeCare beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Cracking The Code: Understanding Analyst Reviews For Addus HomeCare
Via Benzinga
4 Analysts Assess Addus HomeCare: What You Need To Know
Via Benzinga
A Preview Of Addus HomeCare's Earnings
Via Benzinga
ADUS: A Home Health Care Provider With Solid Growth
Addus HomeCare Corp. posted a strong close to fiscal 2023. In Q4, revenues grew 11.9% to $276.4 million, while EPS increased 31.9% to $1.20. 
Via Talk Markets
Addus HomeCare: A Home Health Care Provider With Solid Growth
Addus HomeCare Corp. posted a strong close to fiscal 2023. In Q4, revenues grew 11.9% to $276.4 million, while EPS increased 31.9% to $1.20. As of Dec. 31, 2023, the company had cash of $64.8 million... 
Via Talk Markets
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. 
Via Benzinga
Peeling Back The Layers: Exploring Addus HomeCare Through Analyst Insights
Via Benzinga
Earnings Scheduled For October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter. 
Via Benzinga
Earnings Outlook For Addus HomeCare
Via Benzinga
The Latest Analyst Ratings for Addus HomeCare
Via Benzinga
Analyst Expectations for Addus HomeCare's Future
Via Benzinga
4 Analysts Have This to Say About Addus HomeCare
Via Benzinga
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
Addus HomeCare's Earnings: A Preview
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.